Anthony Durkacz, Executive Co-Chairman of Quantum BioPharma added, “We are very excited about the potential of Lucid-MS as a first-in-class treatment for MS targeting demyelination. With these final ...
A Texas federal judge late Tuesday declined to dismiss a lawsuit against the Food and Drug Administration seeking to sharply restrict the abortion pill mifepristone, instead transferring the case ...
Everyday Health on MSN
Understanding the Shift from Relapsing-Remitting MS to Secondary-Progressive MS
Be ready for the possible transition from RRMS to SPMS by understanding new symptoms, treatment options, and what to discuss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback